inSeption Group Named One of Philadelphia’s Fastest-Growing Companies in 2024 by Philadelphia Business Journal
[Lansdale, PA] – [August 13th, 2024] – inSeption Group, a leading clinical outsourcing company, is proud to announce that it has been named an honoree in the Philadelphia Business Journal’s Fast 50 Growing companies of the greater Philadelphia area.
The Fast 50 award, formerly known as the Soaring 76 award, celebrates companies that have achieved a level of sustained, substantial growth over the past 2 years.
inSeption Group’s distinctive approach to providing clinical research services to biotech and pharma clients has been pivotal in driving sustained growth. By prioritizing quality, adaptability, and employee continuity and aligning experience and passion with each client’s unique needs, inSeption is reshaping the culture of clinical outsourcing.
“It’s no small feat to build a business. Sustaining a high level of growth throughout the years, even through a pandemic, is all the more impressive, and we’re honored to be included on this list with other businesses who have faced and risen above similar challenges. For us, this is yet another signpost letting us know we’re headed in the right direction, one that is pointing to the power of hiring the right people, creating an environment in which they choose to stay, and delivering on our promises.”
For more information about inSeption Group and its award-winning workplace culture, please visit inseptiongroup.com or contact Joe Arcangelo at 267-498-5092 or Brian Sulpizio at 215-855-7403.
About inSeption Group
Founded in 2011, inSeption Group was created with the vision to restore business trust and confidence in the clinical outsourcing industry. Over time, it has become a home for a subset of professionals who hold themselves to high standards of quality and personal accountability. inSeption Group delivers an unparalleled level of service to biotech and pharma companies conducting clinical programs and submissions in oncology, neurodegenerative disorders, and rare disease. In the changing landscape of clinical research, we’re creating a new kind of future. One where integrity outweighs self-interest, where transparency cultivates trust, and where people deliver on their promises.
Media Contact:
Kristin Morris
Senior Director, Corporate Communications
kmorris@inseptiongroup.com
267-397-8980
870 W Main Street | Landsdale, PA
